Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Abstract
Glioblastoma, the most common primary brain tumor in adults, is usually rapidly fatal. The current standard of care for newly diagnosed glioblastoma is surgical resection to the extent feasible, followed by adjuvant radiotherapy. In this trial we compared radiotherapy alone with radiotherapy plus temozolomide, given concomitantly with and after radiotherapy, in terms of efficacy and...
Paper Details
Title
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Published Date
Mar 10, 2005
Volume
352
Issue
10
Pages
987 - 996
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History